Agios Pharmaceuticals, Inc. (AGIO)
USD 24.57
(-4.62%)
USD 24.57
(-4.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -352.08 Million USD | -372.25% |
| 2022 | -74.55 Million USD | -104.65% |
| 2021 | 1.6 Billion USD | 578.71% |
| 2020 | -335.21 Million USD | 15.48% |
| 2019 | -396.61 Million USD | -14.62% |
| 2018 | -346.02 Million USD | -9.97% |
| 2017 | -314.67 Million USD | -58.55% |
| 2016 | -198.47 Million USD | -68.58% |
| 2015 | -117.73 Million USD | -120.04% |
| 2014 | -53.5 Million USD | -35.77% |
| 2013 | -39.4 Million USD | -96.04% |
| 2012 | -20.1 Million USD | 15.2% |
| 2011 | -23.7 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -96.11 Million USD | -17.87% |
| 2024 Q3 | 947.91 Million USD | 1086.2% |
| 2024 Q1 | -81.54 Million USD | 15.0% |
| 2023 Q3 | -91.32 Million USD | -8.97% |
| 2023 Q1 | -71.42 Million USD | -141.47% |
| 2023 FY | -352.08 Million USD | -372.25% |
| 2023 Q2 | -83.8 Million USD | -17.34% |
| 2023 Q4 | -95.94 Million USD | -5.05% |
| 2022 Q4 | 172.22 Million USD | 337.87% |
| 2022 Q3 | -72.4 Million USD | 21.13% |
| 2022 Q2 | -91.8 Million USD | -3.85% |
| 2022 Q1 | -88.4 Million USD | 6.58% |
| 2022 FY | -74.55 Million USD | -104.65% |
| 2021 Q4 | -94.62 Million USD | -6.6% |
| 2021 Q1 | 1.87 Billion USD | 2019.29% |
| 2021 FY | 1.6 Billion USD | 578.71% |
| 2021 Q2 | -86.21 Million USD | -104.6% |
| 2021 Q3 | -88.76 Million USD | -2.96% |
| 2020 Q4 | -97.65 Million USD | 1.34% |
| 2020 FY | -335.21 Million USD | 15.48% |
| 2020 Q1 | -40.25 Million USD | 60.67% |
| 2020 Q3 | -98.97 Million USD | -9.4% |
| 2020 Q2 | -90.47 Million USD | -124.76% |
| 2019 Q4 | -102.35 Million USD | 3.6% |
| 2019 Q2 | -109.87 Million USD | -18.04% |
| 2019 Q1 | -93.07 Million USD | -1.4% |
| 2019 FY | -396.61 Million USD | -14.62% |
| 2019 Q3 | -106.17 Million USD | 3.37% |
| 2018 Q2 | -68.74 Million USD | 24.31% |
| 2018 Q1 | -90.82 Million USD | -2.88% |
| 2018 Q4 | -91.79 Million USD | 3.03% |
| 2018 FY | -346.02 Million USD | -9.97% |
| 2018 Q3 | -94.66 Million USD | -37.7% |
| 2017 Q3 | -77.13 Million USD | 7.16% |
| 2017 Q4 | -88.28 Million USD | -14.45% |
| 2017 FY | -314.67 Million USD | -58.55% |
| 2017 Q1 | -66.16 Million USD | -17.14% |
| 2017 Q2 | -83.08 Million USD | -25.57% |
| 2016 Q1 | -23.19 Million USD | 42.89% |
| 2016 FY | -198.47 Million USD | -68.58% |
| 2016 Q3 | -62.83 Million USD | -12.3% |
| 2016 Q4 | -56.48 Million USD | 10.1% |
| 2016 Q2 | -55.95 Million USD | -141.2% |
| 2015 Q1 | -4.95 Million USD | 81.41% |
| 2015 FY | -117.73 Million USD | -120.04% |
| 2015 Q4 | -40.62 Million USD | -0.9% |
| 2015 Q3 | -40.25 Million USD | -26.21% |
| 2015 Q2 | -31.89 Million USD | -543.47% |
| 2014 Q2 | -18.29 Million USD | -49.38% |
| 2014 Q1 | -12.24 Million USD | 1.08% |
| 2014 FY | -53.5 Million USD | -35.77% |
| 2014 Q4 | -26.66 Million USD | -819.87% |
| 2014 Q3 | 3.7 Million USD | 120.24% |
| 2013 Q3 | -11.17 Million USD | -29.66% |
| 2013 Q2 | -8.62 Million USD | -19.26% |
| 2013 Q1 | -7.22 Million USD | -36.04% |
| 2013 FY | -39.4 Million USD | -96.04% |
| 2013 Q4 | -12.38 Million USD | -10.78% |
| 2012 FY | -20.1 Million USD | 15.2% |
| 2012 Q2 | -5.51 Million USD | -19.05% |
| 2012 Q3 | -4.64 Million USD | 15.74% |
| 2012 Q4 | -5.31 Million USD | -14.38% |
| 2012 Q1 | -4.63 Million USD | 0.0% |
| 2011 FY | -23.7 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -140.501% |
| Alkermes plc | 355.75 Million USD | 198.969% |
| Agenus Inc. | -245.76 Million USD | -43.264% |
| Aptorum Group Limited | -2.82 Million USD | -12364.85% |
| Ardelyx, Inc. | -66.06 Million USD | -432.926% |
| Dyadic International, Inc. | -6.79 Million USD | -5081.223% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -37516.239% |
| Lantern Pharma Inc. | -15.96 Million USD | -2105.853% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1750.282% |
| Novavax, Inc. | -545.06 Million USD | 35.404% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -503.997% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -377.149% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1798.448% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -3425.816% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -496.935% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 5.766% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1346.583% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -842.924% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -113.939% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -380.031% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1635.193% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -465.558% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -983.848% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -165.741% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 20.024% |
| AlloVir, Inc. | -190.41 Million USD | -84.903% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -71.52% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1137.481% |
| Bicycle Therapeutics plc | -180.66 Million USD | -94.886% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -96.639% |
| ChromaDex Corporation | -4.93 Million USD | -7030.174% |
| Chimerix, Inc. | -82.09 Million USD | -328.879% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -689.376% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -244.948% |
| CRISPR Therapeutics AG | -153.61 Million USD | -129.209% |
| Precision BioSciences, Inc. | -61.31 Million USD | -474.191% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -118.786% |
| Fortress Biotech, Inc. | -60.63 Million USD | -480.649% |
| Fortress Biotech, Inc. | -60.63 Million USD | -480.649% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -331.586% |
| ImmuCell Corporation | -5.77 Million USD | -5997.186% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -211.69% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2182.425% |
| Incyte Corporation | 597.59 Million USD | 158.917% |
| Innoviva, Inc. | 179.72 Million USD | 295.907% |
| IO Biotech, Inc. | -86.08 Million USD | -309.01% |
| Jaguar Health, Inc. | -41.3 Million USD | -752.513% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -130.135% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 775.093% |
| ContextLogic Inc. | -317 Million USD | -11.069% |
| MiMedx Group, Inc. | 67.43 Million USD | 622.084% |
| MEI Pharma, Inc. | 17.77 Million USD | 2080.47% |
| NextCure, Inc. | -62.72 Million USD | -461.338% |
| Onconetix, Inc. | -37.4 Million USD | -841.168% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -791.836% |
| Opthea Limited | -220.24 Million USD | -59.864% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -588.222% |
| Vaxcyte, Inc. | -402.26 Million USD | 12.474% |
| PDS Biotechnology Corporation | -42.94 Million USD | -719.911% |
| Precigen, Inc. | -95.9 Million USD | -267.125% |
| Pharming Group N.V. | -10.54 Million USD | -3237.96% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -74.654% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1334.576% |
| PureTech Health plc | -65.69 Million USD | -435.927% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1303.244% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -65.907% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1346.583% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -36.558% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1192.635% |
| Acelyrin, Inc. | -381.64 Million USD | 7.744% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2807017.134% |
| Summit Therapeutics Inc. | -614.92 Million USD | 42.743% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -932.486% |
| Senti Biosciences, Inc. | -92.91 Million USD | -278.919% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -236.286% |
| Elevation Oncology, Inc. | -45.7 Million USD | -670.366% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -901.958% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2593.48% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -5166.836% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1099.128% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4041.725% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -512.189% |
| Seer, Inc. | -86.27 Million USD | -308.09% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -425.544% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -435.373% |
| ESSA Pharma Inc. | -26.58 Million USD | -1224.518% |
| GlycoMimetics, Inc. | -36.89 Million USD | -854.183% |
| GT Biopharma, Inc. | -7.59 Million USD | -4534.566% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -45.876% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -578.07% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 593.051% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -546.959% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -616.792% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -3439.375% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 38.537% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -9712.932% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -589.584% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -43.361% |
| Aptose Biosciences Inc. | -51.2 Million USD | -587.578% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -258.184% |
| Soligenix, Inc. | -6.14 Million USD | -5633.651% |
| Century Therapeutics, Inc. | -136.67 Million USD | -157.613% |
| Kura Oncology, Inc. | -152.63 Million USD | -130.679% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -294.638% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -3241.127% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 62364.665% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -61778.383% |
| Autolus Therapeutics plc | -208.38 Million USD | -68.962% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -389.705% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -397.335% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1524.922% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -56.31% |
| GRI Bio, Inc. | -13.03 Million USD | -2600.683% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -8415.694% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -183.75% |
| IGM Biosciences, Inc. | -246.41 Million USD | -42.884% |
| INmune Bio, Inc. | -30 Million USD | -1073.314% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -218.462% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -734.455% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2105.836% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2129.113% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -489.91% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -248.027% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -27.51% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -48.003% |
| Verastem, Inc. | -87.36 Million USD | -302.999% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -549.753% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -118.233% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -201.812% |
| Histogen Inc. | -10.62 Million USD | -3215.017% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2364.436% |
| Surrozen, Inc. | -43.04 Million USD | -718.01% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2299.891% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -6821.289% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -572.707% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1293.69% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1207.031% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -4113.047% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -133.04% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -619.633% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1084.484% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -3279.708% |
| Apollomics, Inc. | -172.6 Million USD | -103.99% |
| Amarin Corporation plc | -59.11 Million USD | -495.629% |
| Mesoblast Limited | -87.95 Million USD | -300.3% |
| Turnstone Biologics Corp. | -55.2 Million USD | -537.841% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -139.578% |
| Synaptogenix, Inc. | -6.03 Million USD | -5730.716% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2072.31% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -351.279% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7248.231% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -4090.428% |
| Exelixis, Inc. | 207.76 Million USD | 269.465% |
| Better Therapeutics, Inc. | -39.76 Million USD | -785.533% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -144.594% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 33.396% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2792.599% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -4417.024% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1045.039% |
| Gritstone bio, Inc. | -138.49 Million USD | -154.234% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -446.169% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -8702.31% |
| Avid Bioservices, Inc. | -140.75 Million USD | -150.146% |
| Insmed Incorporated | -749.56 Million USD | 53.028% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2217.968% |
| MediWound Ltd. | -6.71 Million USD | -5142.525% |
| OmniAb, Inc. | -50.61 Million USD | -595.565% |
| Alector, Inc. | -130.39 Million USD | -170.025% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -209.599% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -579.09% |
| Zai Lab Limited | -334.62 Million USD | -5.22% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -8.674% |
| Aura Biosciences, Inc. | -76.4 Million USD | -360.8% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -50.06% |
| Immunic, Inc. | -93.61 Million USD | -276.114% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -159.092% |
| Veracyte, Inc. | -74.4 Million USD | -373.211% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -4487.137% |
| FibroGen, Inc. | -284.23 Million USD | -23.873% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1242.208% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4928.471% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1769.557% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 184.875% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1461.02% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 814.595% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2878.472% |
| Galecto, Inc. | -38.34 Million USD | -818.115% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1766.257% |
| Fortrea Holdings Inc. | -3.4 Million USD | -10255.529% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -178.014% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1922.216% |
| XBiotech Inc. | -24.55 Million USD | -1333.758% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -446.169% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -461.723% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -257.718% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1543.198% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -537.921% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 41.961% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -415.842% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -618314.304% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -55.42% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1481.173% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -60.251% |
| NexImmune, Inc. | -32.34 Million USD | -988.56% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -6560.041% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2406.697% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 108.906% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1353.648% |
| Scopus BioPharma Inc. | -11.6 Million USD | -2932.672% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -201.45% |
| Ainos, Inc. | -13.77 Million USD | -2456.819% |
| Pluri Inc. | -20.88 Million USD | -1585.599% |
| Prothena Corporation plc | -147.02 Million USD | -139.47% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -209.199% |
| Celularity Inc. | -196.29 Million USD | -79.367% |
| Rallybio Corporation | -74.56 Million USD | -372.196% |
| Cue Biopharma, Inc. | -50.73 Million USD | -594.002% |
| MeiraGTx Holdings plc | -84.02 Million USD | -319.018% |
| Omeros Corporation | -117.81 Million USD | -198.853% |
| Humacyte, Inc. | -110.77 Million USD | -217.838% |
| Immunocore Holdings plc | -55.28 Million USD | -536.837% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1857.785% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1435.424% |
| Blueprint Medicines Corporation | -506.98 Million USD | 30.552% |
| CalciMedica, Inc. | -34.35 Million USD | -924.793% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -420.263% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -148.993% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -112.371% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -24.301% |
| Pulmatrix, Inc. | -14.12 Million USD | -2393.364% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -900.392% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -326.061% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 26.83% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -235.734% |
| Cytokinetics, Incorporated | -526.24 Million USD | 33.094% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -876.26% |
| Nutriband Inc. | -5.48 Million USD | -6318.739% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -771.074% |
| Vor Biopharma Inc. | -117.86 Million USD | -198.726% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 108.096% |
| Evogene Ltd. | -23.87 Million USD | -1374.467% |
| ProKidney Corp. | -35.46 Million USD | -892.692% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -193.987% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -4387.833% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 45.26% |
| CorMedix Inc. | -46.33 Million USD | -659.806% |
| BioLineRx Ltd. | -60.61 Million USD | -480.869% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -246.053% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -757.371% |
| Atai Life Sciences N.V. | -40.22 Million USD | -775.318% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -336.562% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -366.212% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -20.499% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1163.051% |
| MediciNova, Inc. | -8.57 Million USD | -4007.651% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -185.607% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4103.115% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1255.918% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -47.171% |
| Biomea Fusion, Inc. | -117.25 Million USD | -200.275% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 43.81% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1094.896% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -129.879% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -68.173% |
| Absci Corporation | -110.56 Million USD | -218.441% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1067.788% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -249.165% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -49.23% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2599.915% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -82.465% |
| Allakos Inc. | -185.7 Million USD | -89.599% |
| Imunon, Inc. | -19.51 Million USD | -1704.194% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -261.728% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 431.72% |
| BioAtla, Inc. | -123.46 Million USD | -185.179% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2792.599% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -2089.874% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -7.585% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -852.903% |
| XOMA Corporation | -40.83 Million USD | -762.306% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -245.625% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -197.088% |
| aTyr Pharma, Inc. | -50.38 Million USD | -598.74% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -301.565% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -132.005% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -48.102% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -902.557% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -4251.095% |
| Akari Therapeutics, Plc | -10 Million USD | -3418.066% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -522867.694% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 225.034% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5182.721% |
| UroGen Pharma Ltd. | -102.24 Million USD | -244.361% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -229.692% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -4427.191% |
| Orgenesis Inc. | -55.36 Million USD | -535.986% |
| Entera Bio Ltd. | -8.88 Million USD | -3860.94% |
| GH Research PLC | -35.58 Million USD | -889.373% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1589.482% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -354.965% |
| Xencor, Inc. | -126.08 Million USD | -179.242% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -9249.864% |
| Replimune Group, Inc. | -215.79 Million USD | -63.159% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1555.596% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 14133.001% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5182.721% |
| Portage Biotech Inc. | -75.33 Million USD | -367.338% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4103.115% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -264.273% |
| OncoCyte Corporation | -27.78 Million USD | -1167.37% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2524.152% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -3065.826% |
| Purple Biotech Ltd. | -19.88 Million USD | -1671.066% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -4916.213% |
| scPharmaceuticals Inc. | -54.81 Million USD | -542.379% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1911.226% |
| HilleVax, Inc. | -123.56 Million USD | -184.939% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -3383.605% |
| Tharimmune, Inc. | -9.31 Million USD | -3678.136% |
| Genprex, Inc. | -30.86 Million USD | -1040.903% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -49.237% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1069.961% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -19658.025% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -6548.168% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2092490.633% |
| Savara Inc. | -54.69 Million USD | -543.694% |
| Curis, Inc. | -47.41 Million USD | -642.598% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1067.347% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -2179.612% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -6222.284% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1080.909% |
| BeiGene, Ltd. | -881.7 Million USD | 60.068% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1553.461% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 19.314% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -345.935% |
| Erasca, Inc. | -125.04 Million USD | -181.576% |
| bluebird bio, Inc. | -211.91 Million USD | -66.147% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -6941.06% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 310.02% |
| DBV Technologies S.A. | -72.72 Million USD | -384.129% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -6941.06% |
| Moderna, Inc. | -4.71 Billion USD | 92.531% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -776.779% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -6083.491% |
| Molecular Templates, Inc. | -8.12 Million USD | -4233.924% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -483.043% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -216.06% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -160.128% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -634.757% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -148.95% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -82.988% |
| MacroGenics, Inc. | -9.05 Million USD | -3787.039% |
| RenovoRx, Inc. | -10.23 Million USD | -3341.048% |
| Adicet Bio, Inc. | -142.65 Million USD | -146.806% |
| Prime Medicine, Inc. | -198.13 Million USD | -77.703% |
| Aditxt, Inc. | -32.38 Million USD | -987.334% |
| Adagene Inc. | -18.94 Million USD | -1758.34% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4715.39% |
| Quantum-Si incorporated | -95.96 Million USD | -266.911% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -195.8% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2315.239% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 366.068% |
| SciSparc Ltd. | -5.12 Million USD | -6774.034% |
| Vericel Corporation | -3.18 Million USD | -10964.991% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -292686.934% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1073.417% |
| Generation Bio Co. | -126.61 Million USD | -178.084% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -383.034% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -327.074% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -34.313% |
| Invivyd, Inc. | -198.64 Million USD | -77.247% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -2.958% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -3953.244% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1643.839% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -3465.809% |
| 2seventy bio, Inc. | -217.57 Million USD | -61.827% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1146.815% |
| Clene Inc. | -49.5 Million USD | -611.231% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1479.752% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -612.239% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1255.918% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -7.322% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -981.919% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1649.683% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -256.394% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -370.996% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -118.953% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 42.756% |
| Evaxion Biotech A/S | -22.12 Million USD | -1491.358% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -336.098% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -75.984% |
| Trevena, Inc. | -40.28 Million USD | -773.906% |
| Surrozen, Inc. | -43.04 Million USD | -718.01% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -409.283% |
| Cingulate Inc. | -23.53 Million USD | -1396.022% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -4993.866% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -783.312% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -4466.242% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -290.298% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -474.5% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -491.715% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2845.103% |
| Kronos Bio, Inc. | -112.67 Million USD | -212.487% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -408.82% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -13882237.17% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -309.905% |
| Statera Biopharma, Inc. | -174.4 Million USD | -101.876% |
| ImmunityBio, Inc. | -583.19 Million USD | 39.628% |
| Korro Bio, Inc. | -81.17 Million USD | -333.755% |
| Kineta, Inc. | -14.09 Million USD | -2397.255% |
| BioVie Inc. | -32.12 Million USD | -996.146% |
| Codexis, Inc. | -76.24 Million USD | -361.815% |
| Celularity Inc. | -196.29 Million USD | -79.367% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -64.121% |
| Celcuity Inc. | -63.77 Million USD | -452.043% |
| Virax Biolabs Group Limited | -6.73 Million USD | -5128.872% |
| Cibus, Inc. | -267.62 Million USD | -31.559% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -773.104% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -883.184% |
| IN8bio, Inc. | -30 Million USD | -1073.353% |
| Kodiak Sciences Inc. | -260.49 Million USD | -35.163% |
| Annexon, Inc. | -134.23 Million USD | -162.288% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -200.506% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -475.044% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1016.181% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 3.876% |
| Eyenovia, Inc. | -27.26 Million USD | -1191.54% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1730.717% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -65710.841% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -360.824% |
| Arcellx, Inc. | -70.69 Million USD | -398.073% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -749.613% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -163.114% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1072.181% |
| Moolec Science SA | -51.78 Million USD | -579.853% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -572.296% |
| Geron Corporation | -184.12 Million USD | -91.22% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -738.824% |
| Royalty Pharma plc | 1.13 Billion USD | 131.026% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -158.972% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -3859.692% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1557.413% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -105.096% |
| Humacyte, Inc. | -110.77 Million USD | -217.838% |
| Structure Therapeutics Inc. | -89.62 Million USD | -292.868% |
| 89bio, Inc. | -142.18 Million USD | -147.62% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -410.568% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -3292.965% |
| Genelux Corporation | -28.29 Million USD | -1144.259% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1111.381% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -98.786% |
| Notable Labs, Ltd. | -11.26 Million USD | -3025.781% |
| Liquidia Corporation | -78.5 Million USD | -348.508% |
| Mustang Bio, Inc. | -51.6 Million USD | -582.315% |
| Immunovant, Inc. | -259.33 Million USD | -35.765% |
| Quantum-Si incorporated | -95.96 Million USD | -266.911% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -383.312% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1716.666% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -266.797% |
| Acasti Pharma Inc. | -12.85 Million USD | -2639.345% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1467.772% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2105.836% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -93.038% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -8085.205% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2723.48% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1093.883% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -803.068% |
| PepGen Inc. | -78.62 Million USD | -347.801% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1082.734% |
| United Therapeutics Corporation | 984.8 Million USD | 135.752% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1481.707% |
| Solid Biosciences Inc. | -96.01 Million USD | -266.701% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7248.231% |
| Immuneering Corporation | -53.47 Million USD | -558.458% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -6821.289% |
| Silo Pharma, Inc. | -3.7 Million USD | -9414.136% |
| Belite Bio, Inc | -31.63 Million USD | -1013.075% |
| XOMA Corporation | -40.83 Million USD | -762.306% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -547.637% |
| Bionomics Limited | -15.49 Billion USD | 97.727% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -319.227% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1107.559% |
| uniQure N.V. | -308.47 Million USD | -14.137% |
| Cassava Sciences, Inc. | -97.21 Million USD | -262.167% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4715.39% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -185.253% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1018.592% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -4192.865% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1111.256% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -65710.841% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1242.208% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2035.808% |
| Altimmune, Inc. | -88.44 Million USD | -298.078% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -132.273% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1107.559% |
| Compugen Ltd. | -18.75 Million USD | -1777.402% |
| Peak Bio, Inc. | -1259.26 USD | -27959812.965% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -664.594% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1518.721% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -3.925% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -324.438% |
| Zura Bio Limited | -60.36 Million USD | -483.313% |
| PolyPid Ltd. | -23.86 Million USD | -1375.332% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2138.037% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -324.438% |
| Instil Bio, Inc. | -156.08 Million USD | -125.572% |
| argenx SE | -295.05 Million USD | -19.33% |
| Immunome, Inc. | -106.8 Million USD | -229.652% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -728.559% |
| Verona Pharma plc | -54.36 Million USD | -547.59% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -252.38% |
| Shattuck Labs, Inc. | -87.29 Million USD | -303.317% |
| CervoMed Inc. | -2.17 Million USD | -16111.261% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -182.459% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2544.097% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -708.376% |
| Moolec Science SA | -51.78 Million USD | -579.853% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2036064.109% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -160.579% |
| AnaptysBio, Inc. | -163.61 Million USD | -115.188% |
| Design Therapeutics, Inc. | -66.86 Million USD | -426.589% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -332.466% |
| NeurAxis, Inc. | -14.62 Million USD | -2307.162% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -829.434% |
| Lumos Pharma, Inc. | -34.03 Million USD | -934.518% |
| Achilles Therapeutics plc | -69.66 Million USD | -405.402% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -252.38% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1666.17% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 11801.98% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -13882237.17% |
| Nutriband Inc. | -5.48 Million USD | -6318.739% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -249.651% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -624.357% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -356.717% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -936.467% |
| MoonLake Immunotherapeutics | -36 Million USD | -877.825% |
| Palisade Bio, Inc. | -12.3 Million USD | -2762.504% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -735.837% |
| Beam Therapeutics Inc. | -132.52 Million USD | -165.673% |
| Neurogene Inc. | -36.31 Million USD | -869.485% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -115.456% |
| AEON Biopharma, Inc. | -52.55 Million USD | -569.929% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -258.735% |
| Sesen Bio, Inc. | -19.88 Million USD | -1670.71% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -391.853% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2713.576% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 20.708% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -215.587% |
| Athira Pharma, Inc. | -117.67 Million USD | -199.211% |
| Vaccinex, Inc. | -20.25 Million USD | -1638.62% |
| HCW Biologics Inc. | -24.99 Million USD | -1308.674% |
| XOMA Corporation | -40.83 Million USD | -762.306% |
| Nektar Therapeutics | -276.05 Million USD | -27.542% |
| Arvinas, Inc. | -367.3 Million USD | 4.142% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -522867.694% |
| Merus N.V. | -154.93 Million USD | -127.243% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -261.383% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1021.835% |
| Rezolute, Inc. | -68.45 Million USD | -414.305% |
| Clene Inc. | -49.5 Million USD | -611.231% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2182.807% |
| BeyondSpring Inc. | -21.02 Million USD | -1574.536% |
| Synlogic, Inc. | -57.28 Million USD | -514.657% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2858.474% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3152.245% |
| Peak Bio, Inc. | -1259.26 USD | -27959812.965% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -842.218% |
| Krystal Biotech, Inc. | 10.93 Million USD | 3320.71% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -146.045% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -8.3% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -7522.66% |
| MannKind Corporation | -11.93 Million USD | -2849.305% |
| Ikena Oncology, Inc. | -68.16 Million USD | -416.516% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1575.413% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -278.862% |
| Gossamer Bio, Inc. | -179.81 Million USD | -95.804% |
| CohBar, Inc. | -11.96 Million USD | -2843.358% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1265.317% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1067.788% |
| Legend Biotech Corporation | -518.25 Million USD | 32.063% |
| Mural Oncology plc | -207.44 Million USD | -69.724% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -183.679% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1825.059% |
| Disc Medicine, Inc. | -76.42 Million USD | -360.673% |
| Champions Oncology, Inc. | -7.27 Million USD | -4739.032% |
| REGENXBIO Inc. | -263.49 Million USD | -33.623% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -3217.493% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -641.16% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -826.95% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -251.515% |
| Vaxart, Inc. | -82.46 Million USD | -326.954% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 105590.423% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -837.838% |
| Cellectis S.A. | -101.05 Million USD | -248.398% |
| Longeveron Inc. | -21.41 Million USD | -1544.272% |
| Repare Therapeutics Inc. | -93.79 Million USD | -275.376% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 34.309% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -394.721% |
| Revolution Medicines, Inc. | -436.36 Million USD | 19.314% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -5258.21% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1042.253% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -407.822% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -443.916% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -3488.707% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 109.727% |
| Denali Therapeutics Inc. | -145.22 Million USD | -142.445% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -292686.934% |
| Veru Inc. | -93.15 Million USD | -277.969% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1202.631% |
| Cingulate Inc. | -23.53 Million USD | -1396.022% |
| Passage Bio, Inc. | -102.06 Million USD | -244.975% |
| Context Therapeutics Inc. | -23.96 Million USD | -1369.224% |
| Exicure, Inc. | -16.91 Million USD | -1981.637% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -86.372% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -832.338% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -5310.642% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -90.65% |
| Nuvalent, Inc. | -126.21 Million USD | -178.95% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -3248.227% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -305.262% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1052.724% |
| OmniAb, Inc. | -50.61 Million USD | -595.565% |
| Anew Medical, Inc. | 1.34 Million USD | 26255.669% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2094.378% |
| Lipocine Inc. | -16.35 Million USD | -2053.169% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -430.301% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -452.945% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -734.455% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -634.021% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1675.442% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 34.978% |
| Ocugen, Inc. | -63.07 Million USD | -458.179% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -267.785% |
| Q32 Bio Inc. | -112.96 Million USD | -211.69% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1947.976% |
| Alumis Inc. Common Stock | -154.99 Million USD | -127.164% |
| Equillium, Inc. | -13.33 Million USD | -2540.33% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -483.255% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -4307.802% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1767.719% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -495.931% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -207.428% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1815.817% |
| Dominari Holdings Inc. | -22.88 Million USD | -1438.712% |
| Edesa Biotech, Inc. | -8.37 Million USD | -4104.329% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1638.706% |
| Bio-Techne Corporation | 168.1 Million USD | 309.445% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 373.248% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -188.995% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -828.037% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -212.573% |
| Nkarta, Inc. | -117.5 Million USD | -199.647% |
| BioCardia, Inc. | -11.57 Million USD | -2942.849% |
| Iterum Therapeutics plc | -38.37 Million USD | -817.589% |